DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $28,494,000 | -48.2% | 735,898 | -47.4% | 0.16% | -49.8% |
Q2 2018 | $55,042,000 | +33.4% | 1,398,791 | -32.1% | 0.32% | +27.0% |
Q1 2018 | $41,259,000 | -24.0% | 2,058,842 | -14.0% | 0.25% | -25.7% |
Q4 2017 | $54,286,000 | +14.7% | 2,394,625 | -3.9% | 0.33% | +9.2% |
Q3 2017 | $47,314,000 | – | 2,491,542 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |